References
1. Bohman Ya.V. Guide on oncogynecology. Saint Petersburg, 2002. (in Russian)
2. Torre L.A., Bray F., Siegel R.L., Ferlay J., et al. Global cancer statistics, 2012. CA Cancer J. Clin. 2015; 65 (2): 87-108.
3. Kostin A.A., Starinsky V.V., Samsonov Yu.V., Asratov A.T. Analysis of statistical data on malignant tumors associated with human papillomavirus. Issledovaniya i praktika v meditsine [Research'n Practical Medicine Journal]. 2016; 3 (1): 66-78. (in Russian)
4. Wiebe E., Denny L., Thomas G. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2012; 119 (suppl. 2): S100-9.
5. Khokhlova S.V., Kolomiets L.A., Kravets O.A., Krikunova L.I. et al. Practical guidelines for medical therapy of cervical cancer. Practical recommendations of the Russian Society of Clinical Oncology for the treatment of malignant tumors. Moscow: RUSSCO, 2016. (in Russian)
6. Eifel P.J. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol. 2006; 16 (3): 177-85.
7. NCCN News. J Natl Compr Cancer Netw. 2017; 15 (1): xxvi-xxvii.
8. Ferrandina G., Distefano M.G., De Vincenzo R., Salutari V., et al. Pa-clitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results. Gynecol Oncol. 2013; 128 (3): 518-23.
9. Landoni F., Maneo A., Colombo A., Placa F., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997; 350 (9077): 535-40.
10. Pfaendler K.S., Tewari K.S. Changing paradigms in the systemic treatment of advanced cervical cancer. Am J Obstet Gynecol. 2016; 214 (1): 22-30.
11. Colombo N., Carinelli S., Colombo A., Marini C., et al. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 (suppl. 7): vii27-vii32.
12. Kveladze V.V. Multicomponent treatment of patients with locally advanced cervical cancer in conditions of induction polychemotherapy. Multicomponent treatment of patients with locally advanced cervical cancer in conditions of induction polychemotherapy. Chelyabinsk, 2005: 136. (in Russian)
13. Titova V.A., Kharchenko N.V., Stolyarova I.V. Automated radiation therapy for female reproductive system cancer (cervix, endometrium, ovaries, vulva, vagina). Moscow: Meditsina, 2006. (in Russian)
14. Al Feghali K.A., Elshaikh M.A. Why brachytherapy boost is the treatment of choice for most women with locally advanced cervical carcinoma? Brachytherapy. 2016; 15 (2): 191-9.
15. Shevchenko L.N. Radiation therapy for locally advanced cervical cancer in conditions of local laser-induced hyperthermia. Literature review. Vestnik RNTSRR [Bulletin of RSCRR]. 2010; 10: 14. (in Russian)
16. Maksimov S.Ya. Primary multiple tumors of reproductive system. Prakticheskaya onkologiya [Practical Oncology]. 2009; 10 (2): 117-23. (in Russian)
17. Shunko E.L. X-ray and chemotherapy as factors of multiple primary malignant neoplasms development (literature review). Sovremennyy prob-lemy nauki i obrazovaniya [Modern Problems of Science and Education]. 2011; 6: 10. (in Russian)
18. Solenova L.G. Second primary tumors in oncologic patients: epidemiology, the role of antineoplastic therapy. Uspekhi molekulyarnoy onkol-ogii [Advances in Molecular Oncology].2016; 3: 30-42. (in Russian)
19. Keys H.M., Bundy B.N., Stehman F.B., Okagaki T. et al.; Gynecologic Oncology Group. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol. 2003; 89 (3): 343-53.
20. Kokka F., Bryant A., Brockbank E., Powell M., et al. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev. 2015; 4. CD010260. doi: 10.1002/14651858.CD010260.pub2.
21. Monk B.J., Wang J., Im S., Stock R.J., et al.; Gynecologic Oncology Group, Southwest Oncology Group, Radiation Therapy Oncology Group. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005; 96 (3): 721-8.
22. Benedetti-Panici P., Greggi S., Colombo A., Amoroso M., et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002; 20 (1): 179-88.
23. Tyulyandin S.A., Maryina L.A. Chemotherapy of locally advanced cervical cancer. In: Chemotherapy for locally advanced cervical cancer. Moscow, 2003. (in Russian)
24. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999; 17 (5): 1339-48.
25. Churuksaeva O.N., Kolomiets L.A. Neoadjuvant chemotherapy in locally advanced cervical cancer treatment. Sibirskiy onkologicheskiy zhurnal [Siberian Oncology Journal]. 2013; 56 (2): 18-24. (in Russian)
26. Wieringa H.W., van der Zee A.G., de Vries E.G., van Vugt M.A. Breaking the DNA damage response to improve cervical cancer treatment. Cancer Treat Rev. 2016; 42: 30-40.
27. Yin M., Zhang H., Li H., Li X., et al. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer. J Surg Oncol. 2012; 105 (2): 206-11.
28. Menshenina A.P., Moiseenko T.I., Ushakova N.D. Possibilities of preoperative polychemotherapy optimization in patients with invasive cervical cancer. З Zlokachestvennyye opukholi [Malignant Tumors]. 2014; 3: 30-6. (in Russian)
29. Perevodchikova N.I., Gorbunova V.A. Guidelines for tumor diseases chemotherapy. 4th ed. by N.I. Perevodchikova, V.A. Gorbunova. Moscow: Practical medicine, 2015. (in Russian)
30. Bohr Mordhorst L., Karlsson L., Barmark B., Sorbe B. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for treatment outcome and early and late radiation reactions. Int J Gynecol Cancer. 2014; 24 (7): 1268-75.
31. Gao K., Ding L., Li L. [Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer]. Zhonghua Fu Chan Ke Za Zhi. 2014. Vol. 49 (1): 30-5.
32. Barillot I., Horiot J. C., Pigneux J., Schraub S., et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys. 1997; 38 (5): 969-78.
33. Panici P.B., Di Donato V., Palaia I., Visentin V.S., et al. Type B versus type C radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical carcinoma: a propensity-matched analysis. Ann Surg Oncol. 2016; 23 (7): 2176-82.
34. Ashrafyan L.A., Antonova I.B., Aleshikova O.I., Dobrovolskaya N.Yu. et al. Diagnostic aids and factors of efficiency forecast of neoadjuvated chemotherapy for locally advanced cervical cancer (IIb - IIIb stages). Opukholi zhenskoy reproduktivnoy sistemy [Tumors of Female Reproductive System]. 2007; 4: 63-71. (in Russian)
35. Angioli R., Plotti F., Luvero D., Aloisi A., et al. Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study. Tumour Biol. 2014; 35 (3): 2741-6.
36. Osman M. The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review. Oncol Rev. 2014; 8 (2): 250.
37. Teletaeva G.M. Prevention and treatment of drug therapy gastrointestinal complications (nausea and vomiting, mucositis, diarrhea). Prakticheskaya onkologiya [Practical Oncology]. 2009; 10 (3): 158-67. (in Russian)
38. Petrova G.D., Chernyavskaya T.Z., Gorbunova N.V., Kostrykina V.N. et al. Efficacy of lipagfilgrastim in case of neutropenia which was induced by chemotherapy. Onkogematologiya [Oncohematology]. 2015; 10 (4): 38-43. (in Russian)
39. Nagai N., Oshita T., Murakami J., Shigemasa K., et al. Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoro-pyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: a prospective follow-up study Oncol Rep. 2001; 8 (1): 119-25.
40. Ashrafyan L.A., Kiselev V.I. Modern Oncology. Molecular biology and prospects of effective therapy. Moscow: Molodaya gvardiya, 2015. (in Russian)
41. Kurmyshkina O.V., Belova L.L., Kovchur P.I., Volkova T.O. Remodeling of angiogenesis and lymphangiogenesis in development of cervical cancer. Biomeditsinskaya khimiya [Biomedical Chemistry]. 2015; 5: 57997. (in Russian)
42. Duenas-Gonzalez A., Cetina L., Mariscal I., de la Garza J. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev. 2003. Vol. 29 (5): 389-99.